BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 24, 2025
Home
»
Topics
»
Disease categories and therapies
» Endocrine/metabolic
Endocrine/metabolic
RSS
Merck & Co. reports on L-163689
Aug. 30, 1996
Aldose reductase/5-lipoxygenase inhibitors reported by Tsumura
Aug. 30, 1996
Aldose reductase inhibitors from Terumo
Aug. 30, 1996
Sankyo reports novel hypoglycemic agents
Aug. 30, 1996
Positive efficacy/safety profile for maximal-dose sulfonylurea therapy reported
Aug. 30, 1996
Beta3-adrenoceptor agonists described by Dainippon
Aug. 30, 1996
Cangene and Cheil Jedang sign Leucotropin agreement
Aug. 30, 1996
CCK antagonists from Warner-Lambert
Aug. 30, 1996
NGD-95-1 demonstrates safety in phase I
Aug. 30, 1996
More squalene synthase inhibitors from Pfizer
Aug. 30, 1996
Previous
1
2
…
1781
1782
1783
1784
1785
1786
1787
1788
1789
…
1809
1810
Next
RSS